Skip to main content
Log in

Renal transplantation in patients with familial Mediterranean fever

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Amyloidosis is the most common and devastating complication of familial Mediterranean fever (FMF). Renal transplantation is the choice of treatment of in most end-stage renal disease (ESRD). We report our experience on the outcomes in eight patients who underwent renal transplantation for ESRD due to FMF secondary to amyloidosis, and we provide a discussion on the current evidence on this topic of study. The clinical charts of eight renal transplant patients (seven male, one female) who underwent ESRD due to FMF-related amyloidosis were investigated. Five patients underwent living-donor renal transplantation and three patients underwent deceased-donor renal transplant. The mean follow-up period was 35 months (range 3–72). All patients were on triple immunosuppressive treatment and received colchicine. All allografts are currently functioning well with a mean serum creatinine level of 1.4 (range 0.7–2.6) mg/dL. Posttransplantation complications included acute rejection (n = 4), chronic rejection (n = 1), severe gastroenteritis (n = 2), and erythrocytosis (n = 5). None of the patients had proteinuria. During follow-up, we did not observe clinically severe FMF attack, septicemia, rhabdomylosis, symptoms related to vasculitis, and clinical neuropathy. The clinical outcome of the patients in this cohort was similar to that of other renal transplant patients with ESRD due to other causes. This study shows favorable prognosis of eight ESRD patients due to amyloidosis caused by FMF after renal transplantation. Renal transplantation is a safe procedure for ESRD patients having amyloidosis due to FMF. Regular use of colchicine after transplantation should be mentioned.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Perfetto F, Moggi-Pignone A, Livi R, Tempestini A, Bergesio F, Matucci-Cerinic M (2010) Systemic amyloidosis: a challenge for the rheumatologist. Nat Rev Rheumatol 6:417–429

    Article  PubMed  CAS  Google Scholar 

  2. Röcken C, Shakespeare A (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440:111–122

    Article  PubMed  Google Scholar 

  3. Picken MM (2007) New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens 16:196–203

    Article  PubMed  Google Scholar 

  4. Kastner DL, Aksentijevich I, Goldbach-Mansky R (2010) Autoinflammatory disease reloaded: a clinical perspective. Cell 140:784–790

    Article  PubMed  CAS  Google Scholar 

  5. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Med (Baltimore) 84:1–11

    Article  Google Scholar 

  6. Akpolat T, Ozkaya O, Ozen S (2012) Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients. Gene 492:285–289

    Article  PubMed  CAS  Google Scholar 

  7. Keven K, Sengul S, Kutlay S, Ekmekci Y, Anadol E, Nergizoglu G, Ates K, Erturk S, Erbay B (2004) Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience. Transplant Proc 36:2632–2634

    Article  PubMed  CAS  Google Scholar 

  8. Altiparmak MR, Pamuk ON, Ataman R, Serdengeçti K (2004) Continuous ambulatory peritoneal dialysis in familial Mediterranean fever amyloidosis patients with end-stage renal failure: a single-centre experience from Turkey. Nephron Clin Pract 98:119–123

    Article  Google Scholar 

  9. Ari JB, Zlotnik M, Oren A, Berlyne GM (1976) Dialysis in renal failure casued by amyloidosis of familial Mediterranean fever. A report of ten cases. Arch Intern Med 136:449–451

    Article  PubMed  CAS  Google Scholar 

  10. Saglam F, Celik A, Cavdar C, Sifil A, Atila K, Kaya GC, Bora S, Gulay H, Camsari T (2008) A renal transplant recipient with delayed gastric emptying in amyloidosis due to familial Mediterranean fever improved with erythromycin: a case report. Transplant Proc 40:308–309

    Article  PubMed  CAS  Google Scholar 

  11. Terkeltaub RA (2009) Colchicine update: 2008. Semin Arthritis Rheum 38:411–419

    Article  PubMed  CAS  Google Scholar 

  12. Emiroglu R, Başaran O, Pehlivan S, Ozdemir FN, Colak T, Moray G, Noyan T, Haberal M (2005) Effect of amyloidosis on long-term survival in kidney transplantation. Transplant Proc 37:2967–2968

    Article  PubMed  CAS  Google Scholar 

  13. Sherif AM, Refaie AF, Sobh MA, Mohamed NA, Sheashaa HA, Ghoneim MA (2003) Long-term outcome of live donor kidney transplantation for renal amyloidosis. Am J Kidney Dis 42:370–375

    Article  PubMed  Google Scholar 

  14. Jacob ET, Bar-Nathan N, Shapira Z, Gafni J (1979) Renal transplantation in the amyloidosis of familial Mediterranean fever. Experience in ten cases. Arch Intern Med 139:1135–1138

    Article  PubMed  CAS  Google Scholar 

  15. Russell PS, Winn HJ (1970) Transplantation. II. N Engl J Med 282:848–854

    Article  PubMed  CAS  Google Scholar 

  16. Turkmen A, Yildiz A, Erkoc R, Ecder T, Görçin B, Türk S, Aydin AE, Eldegez U, Ark E, Sever MS (1998) Transplantation in renal amyloidosis. Clin Transplant 12:375–378

    PubMed  CAS  Google Scholar 

  17. Heering P, Hetzel R, Grabensee B, Opelz G (1998) Renal transplantation in secondary systemic amyloidosis. Clin Transplant 12:159–164

    PubMed  CAS  Google Scholar 

  18. Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D, Rush D, Cole E (2005) Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation. CMAJ 173:1–25

    Article  Google Scholar 

  19. Goeminne A, Missault L, Bauwens F, De Pauw M, De Sutter J (2003) Clinical experience with cardiac amyloidosis. Acta Cardiol 58:143–147

    Article  PubMed  Google Scholar 

  20. Livneh A, Zemer D, Siegal B, Laor A, Sohar E, Pras M (1992) Colchicine prevents kidney transplant amyloidosis in familial Mediterranean fever. Nephron 60:418–422

    Article  PubMed  CAS  Google Scholar 

  21. Cohen AS, Bricetti AB, Harrington JT, Mannick JA (1971) Renal transplantation in two cases of amyloidosis. Lancet 2:513–516

    Article  PubMed  CAS  Google Scholar 

  22. Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, Kastner DL (1998) Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Med (Baltimore) 77:268–297

    Article  CAS  Google Scholar 

  23. McMullin MF (2009) Idiopathic erythrocytosis: a disappearing entity. Hematol Am Soc Hematol Educ Program 629–635

  24. Kivity S, Danilesko I, Ben-Zvi I, Gilburd B, Kukuy OL, Rahamimov R, Livneh A (2011) Serum amyloid A levels in kidney-transplanted patients with familial Mediterranean fever-amyloidosis. Isr Med Assoc J 13:202–205

    PubMed  Google Scholar 

  25. Sherif AM, Refaie AF, Sheashaa HA, El-Tantawy AE, Sobh MA (2004) Long-term evaluation of neuromyopathy in live donor FMF amyloidotic kidney transplant recipients. Am J Nephrol 24:582–586

    Article  PubMed  Google Scholar 

  26. Ozdemir BH, Ozdemir FN, Sezer S, Sar A, Haberal M (2006) Does colchicine have an antifibrotic effect on development of interstitial fibrosis in renal allografts of recipients with familial Mediterranean fever? Transplant Proc 38:473–476

    Article  PubMed  CAS  Google Scholar 

  27. Ozdemir BH, Karabay G, Ozdemir FN, Demirhan B, Haberal M (2003) Early detection of amyloidosis in renal allografts: electron microscopic, histochemical, immunohistochemical findings and relationship with graft survival. Transplant Proc 35:2639–2640

    Article  PubMed  CAS  Google Scholar 

  28. Cohen SL, Boner G, Shmueli D, Yusim A, Rosenfeld J, Shapira Z (1989) Cyclosporin: poorly tolerated in familial Mediterranean fever. Nephrol Dial Transplant 4:201–204

    PubMed  CAS  Google Scholar 

  29. Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A (2002) Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers. Isr Med Assoc J 4:935–939

    PubMed  CAS  Google Scholar 

  30. Celik A, Saglam F, Dolek D, Sifil A, Soylu A, Cavdar C, Temizkan A, Bora S, Gulay H, Camsari T (2006) Outcome of kidney transplantation for renal amyloidosis:a single-center experience. Transplant Proc 38:435–439

    Article  PubMed  CAS  Google Scholar 

  31. Serrano R, Martínez MA, Andrés A, Morales JM, Samartin R (1998) Familial mediterranean fever and acute myocardial infarction secondary to coronary vasculitis. Histopathology 33:163–167

    Article  PubMed  CAS  Google Scholar 

  32. Henckes M, Roskams T, Vanneste S, Van Damme B, Vanrenterghem Y (1994) Polyarteritis nodosa type vasculitis in a patient with familial Mediterranean fever treated with cyclosporin A. Transpl Int 7:292–296

    Article  PubMed  CAS  Google Scholar 

  33. Vergoulas G, Papagiannis A, Takoudas D, Papanikolaou V, Gakis D, Antoniadis A (1992) Renal transplantation and pregnancy in a patient with familial Mediterranean fever amyloidosis taking triple-drug immunosuppression and colchicine. Nephrol Dial Transplant 7:273–274

    PubMed  CAS  Google Scholar 

  34. Silver J, Rosler A, Friedlander M, Popovtzer MM (1982) Unmasking of isolated hypoaldosteronism after renal allotransplantation in familial Mediterranean fever. Isr J Med Sci 18:495–498

    PubMed  CAS  Google Scholar 

  35. Moser C, Pohl G, Haslinger I, Knapp S, Rowczenio D, Russel T, Lachmann HJ, Lang U, Kovarik J (2009) Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation. Nephrol Dial Transplant 24:676–678

    Article  PubMed  CAS  Google Scholar 

  36. Khosroshahi HT, Tubbs RS, Shoja MM (2006) Familial Mediterranean fever triggered by renal transplantation. Nephrol Dial Transplant 21:3000–3001

    Article  PubMed  Google Scholar 

  37. Koç M, Bihorac A, Ozener CI, Kantarci G, Akoglu E (2000) Severe hyperkalemia in two renal transplant recipients treated with standard dose of trimethoprim-sulfamethoxazole. Am J Kidney Dis 36:E18

    Article  PubMed  Google Scholar 

  38. Emeksiz H, Bakkaloglu S, Camurdan O, Boyraz M, Soylemezoglu O, Hasanoglu E, Buyan N (2010) Acute adrenal crisis mimicking familial Mediterranean fever attack in a renal transplant FMF patient with amyloid goiter. Rheumatol Int 30:1647–1649

    Article  PubMed  Google Scholar 

Download references

Disclosures

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emre Erdem.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erdem, E., Karatas, A., Kaya, C. et al. Renal transplantation in patients with familial Mediterranean fever. Clin Rheumatol 31, 1183–1186 (2012). https://doi.org/10.1007/s10067-012-1992-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-012-1992-6

Keywords

Navigation